Literature DB >> 16166315

BAD Ser128 is not phosphorylated by c-Jun NH2-terminal kinase for promoting apoptosis.

Jiyan Zhang1, Jing Liu, Chenfei Yu, Anning Lin.   

Abstract

The phosphorylation and regulation of the proapoptotic Bcl-2 family protein BAD by c-Jun NH2-terminal kinase (JNK) is controversial. JNK can suppress interleukin-3 withdrawal-induced apoptosis via phosphorylation of BAD at Thr201. However, it has also been reported that JNK promotes apoptosis through phosphorylation of BAD at Ser128. Here, we report that JNK is not a BAD Ser128 kinase. JNK phosphorylates murine BAD (mBAD), but not human BAD (hBAD), in which Ser91 is equivalent to Ser128 in mBAD. In contrast, Cdc2, which phosphorylates Ser128, phosphorylates both mBAD and hBAD. Replacement of Ser128 by alanine has no effects on BAD phosphorylation by JNK in vitro and in vivo. Two-dimensional phosphopeptide mapping in combination with phosphoamino acid analysis reveals that JNK does not phosphorylate BAD at Ser128. Elimination of Ser128 phosphorylation has no effects on the proapoptotic activity of BAD in apoptosis induced by UV via JNK or growth factor withdrawal. Thus, our results show that Ser128 is not phosphorylated by JNK for promoting cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166315     DOI: 10.1158/0008-5472.CAN-05-0576

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  Phosphorylation of Bcl-associated death protein (Bad) by erythropoietin-activated c-Jun N-terminal protein kinase 1 contributes to survival of erythropoietin-dependent cells.

Authors:  Hongbin Deng; Jingpu Zhang; Taewon Yoon; Danqing Song; Diandong Li; Anning Lin
Journal:  Int J Biochem Cell Biol       Date:  2010-11-21       Impact factor: 5.085

3.  BAD contributes to RAF-mediated proliferation and cooperates with B-RAF-V600E in cancer signaling.

Authors:  Lisa Polzien; Angela Baljuls; Marco Albrecht; Mirko Hekman; Ulf R Rapp
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

4.  Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation.

Authors:  Lisa Polzien; Angela Baljuls; Ulrike E E Rennefahrt; Andreas Fischer; Werner Schmitz; Rene P Zahedi; Albert Sickmann; Renate Metz; Stefan Albert; Roland Benz; Mirko Hekman; Ulf R Rapp
Journal:  J Biol Chem       Date:  2009-08-10       Impact factor: 5.157

5.  Differential cardiotoxic/cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy.

Authors:  Giovanni Fajardo; Mingming Zhao; Jennifer Powers; Daniel Bernstein
Journal:  J Mol Cell Cardiol       Date:  2006-02-03       Impact factor: 5.000

6.  Cyclic AMP inhibits p38 activation via CREB-induced dynein light chain.

Authors:  Jiyan Zhang; Truc N Bui; Jialing Xiang; Anning Lin
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

7.  Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis.

Authors:  Xuefei Cao; Carmen Plasencia; Atsuko Kanzaki; Austin Yang; Terrence R Burke; Nouri Neamati
Journal:  Curr Cancer Drug Targets       Date:  2009-03       Impact factor: 3.428

8.  Defective anchoring of JNK1 in the cytoplasm by MKK7 in Jurkat cells is associated with resistance to Fas-mediated apoptosis.

Authors:  Jing Wang; Ruihong Tang; Ming Lv; Qingyang Wang; Xueying Zhang; Yuanyuan Guo; Hong Chang; Chunxia Qiao; He Xiao; Xinying Li; Yan Li; Beifen Shen; Jiyan Zhang
Journal:  Mol Biol Cell       Date:  2010-12-09       Impact factor: 4.138

9.  Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells.

Authors:  Zhang-Zhi Hu; Benjamin L Kagan; Eric A Ariazi; Dean S Rosenthal; Lihua Zhang; Jordan V Li; Hongzhan Huang; Cathy Wu; V Craig Jordan; Anna T Riegel; Anton Wellstein
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

10.  Selective unresponsiveness to the inhibition of p38 MAPK activation by cAMP helps L929 fibroblastoma cells escape TNF-alpha-induced cell death.

Authors:  Jing Wang; Ruihong Tang; Ming Lv; Jiyan Zhang; Beifen Shen
Journal:  Mol Cancer       Date:  2010-01-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.